In addition, the treatment of JPH203 caused the downregulation of BMI1 or SOX2 (Figure 3C), two of the stemness genes which have been demonstrated to participate in CSC maintenance in NSCLC [21]. This evidence concerns the gene BMI1 and non-small cell lung carcinoma.